MedTrace Logo

Feasibility of the mNIHSS in Surgical Patients

NCT04044807 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2019-09-25

No results posted yet for this study

Summary

This prospective observational study will be assessing whether it is practical and feasible to use a stroke screening tool (the modified NHISS, mNIHSS) in an adult surgical population. Perioperative stroke is an uncommon but devastating complication of surgery and previous research suggests that stroke symptoms may be missed in this population. This stroke screening tool has been used extensively in non-surgical patients but has not be used in non-cardiac surgical patients. Surgical patients have additional factors that may affect their ability to complete this assessment such as pain medications and sedatives, pain, and use of epidurals and nerve blocks. This study will involve a total of five testing sessions. The first will occur at the time of consent to screen for cognitive impairment via the Montreal Cognitive Assessment (MoCA), as part of our exclusion criteria. Then over the course of four subsequent visits, participants will be assessed on the mNIHSS to track for any changes before and after their procedure, as well as evaluate the real-life usability of the mNIHSS as a potential tool to screen for stroke in the surgical population.

Conditions

  • Stroke, Acute
  • Stroke, Complication

Interventions

DIAGNOSTIC_TEST

Modified National Institutes of Health Stroke Scale

Clinical tool used in the diagnosis of acute stroke developed by the National Institutes of Health, and modified for simplicity.

Sponsors & Collaborators

  • Vancouver General Hospital

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-06
Primary Completion
2019-09-01
Completion
2019-09-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04044807 on ClinicalTrials.gov